Showing results (61-70 of 284) with videos related to
Sort By:
Pageof 29
Circulation|June 4, 1998
C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarctionP M Ridker, R J Glynn, C H HennekensThrombosis and Haemostasis|July 1, 1997
Postmenopausal hormone replacement therapy and cardiovascular diseaseC U Chae, P M Ridker, J E MansonArteriosclerosis, Thrombosis, and Vascular Biology|July 9, 1999
Cross-sectional study of soluble intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy menL E Rohde, C H Hennekens, P M RidkerJAMA|November 10, 1993
A prospective study of lipoprotein(a) and the risk of myocardial infarctionP M Ridker, C H Hennekens, M J StampferCirculation|December 1, 1993
Ventricular arrhythmias in trials of thrombolytic therapy for acute myocardial infarction. A meta-analysisS D Solomon, P M Ridker, E M AntmanJAMA|April 26, 1995
Plasma concentration of lipoprotein(a) and the risk of future strokeP M Ridker, M J Stampfer, C H HennekensClinical Chemistry and Laboratory Medicine|July 27, 1999
Inflammation, the acute phase response and atherosclerosisJ Whicher, L Biasucci, N RifaiClinical Chemistry|May 1, 1996
Three routine methods for measuring high-density lipoprotein cholesterol compared with the Reference MethodN Harris, V Galpchian, N RifaiTherapeutic Drug Monitoring|October 1, 1995
Assessment of the immunoreactivity of digoxin metabolites and the cross-reactivity with digoxin-like immunoreactive factors in the Roche-TDM ONLINE digoxin assayE Bonagura, T Law, N RifaiAtherosclerosis|February 1, 1992
Lipoprotein(a) at birth, in blacks and whitesN Rifai, G Heiss, K DoetschPageof 29